Tag: Trials
Parexel names Keri Mattox as Chief Business Officer
Healthcare executive to lead company’s business operations and growth strategy
Ahammune Biosciences raises USD 5 million in series A funding led...
The recently raised funding will assist the company in conducting human clinical trials for its promising drug candidate in vitiligo patients
Fujitsu tackles ‘drug loss’ in Japan through ecosystem to accelerate digitalization...
Fujitsu forms strategic partnership with Paradigm and will provide offerings that leverage the power of AI
Lupin completes Phase 3 trials for Lucentis Biosimilar
The successful completion of the global Phase 3 trials paves the way to obtain marketing approval in the U.S. and EU
Anticipation builds as Insmed bronchiectasis therapy brensocatib nears Phase III completion
The projected sales of brensocatib may further reflect the great significance and impact of its potential approval on the bronchiectasis market
Zydus Lifesciences initiates Phase II clinical trial of ZYIL1, a potential...
The USFDA has granted Zydus an ‘Orphan Drug Designation’ for ZYIL1 to treat patients with Cryopyrin Associated Periodic Syndrome (CAPS), a rare auto-inflammatory disease
Roche Pharma launches clinical trial excellence project in India
Program partners with government hospitals to strengthen drug development in the country
Pfizer initiates Phase 3 Study of mRNA-based Influenza vaccine
First Phase 3 efficacy study to be conducted using an mRNA-based influenza vaccine; study will enroll 25,000 U.S. adults 18 years and older
Bharat Biotech’s iNCOVACC, world’s first Intra Nasal vaccine, gets emergency use...
Heterologous booster dose studies were conducted for safety and immunogenicity in ~875 subjects at 9 trial sites across India
“India continues to remain a key destination for clinical trials”
Jinu Jose, Vice President, Head – Sales and Clinical Operations, R&D Solutions, IQVIA India shared his views on the company's current operations, market scenario and future outlook